Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

Meanwhile, the FDA also approved Genetech's TNKase to treat adults who suffer acute ischemic stroke. THNKase (tenecteplace) is a single-dose intravenous bolus that is faster and easier to ...

Chappell Roan tops this week's Official Trending Chart with The Giver. The Missouri-born pop auteur also looks set to replace herself at the top of this week's Official Singles Chart, with country ...

Sabrina Carpenter's impact on the Official Albums Chart is anything but Short N’ Sweet as she claims the Number 1 album of 2025 so far. Racking up 196,000 chart units this year alone (with an ...

Tiziana Life Sciences (TLSA) announced dosing has commenced at Johns Hopkins University, JHU, Autoimmunity Center of Excellence, the third ...

Amvuttra (vutrisiran) Transthyretin-directed small interfering RNA therapeutic Treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce ...

By Xander Zellner Lady Gaga is back with a monster week on Billboard’s charts, thanks to her new album, MAYHEM. The set blasts in at No. 1 on the Billboard 200 with 219,000 equivalent album ...

The chart below provides highlights of key monograph updates made this month (not an inclusive list). Click on the name of the drugs to view the full monographs on eMPR.com.

Market sentiment charts show selling pressure subsiding, but panic could trigger a bullish turn. The stock market's constant reaction to policy uncertainty and tariffs has dominated the news over ...

Here’s a look at 23andMe’s rise and fall in four charts. Just months after it started trading on the Nasdaq in June 2021, the company was valued as high as $5.8 billion. But by the end of that ...

Swiss pharma giant Roche RHHBY faced a setback in its efforts to develop a higher dose of multiple sclerosis ... The company recently obtained FDA approval for TNKase (tenecteplase), a ...